Skip to main content
Top
Published in: Clinical Research in Cardiology 11/2019

Open Access 01-11-2019 | Heart Failure | Original Paper

Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit

Authors: Simon G. Anderson, Ahmad Shoaib, Phyo Kyaw Myint, John G. Cleland, Suzanna M. Hardman, Theresa A. McDonagh, Henry Dargie, Bernard Keavney, Clifford J. Garratt, Mamas A. Mamas

Published in: Clinical Research in Cardiology | Issue 11/2019

Login to get access

Abstract

Background

Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with acute heart failure (AHF). The presence of AF is associated with adverse prognosis in patients with chronic heart failure (CHF) but little is known about its impact in AHF.

Methods

Data were collected between April 2007 and March 2013 across 185 (> 95%) hospitals in England and Wales from patients with a primary death or a discharge diagnosis of AHF. We investigated the association between the presence of AF and all-cause mortality during the index hospital admission, at 30 days and 1 year post-discharge.

Results

Of 96,593 patients admitted with AHF, 44,642 (46%) were in sinus rhythm (SR) and 51,951 (54%) in AF. Patients with AF were older (mean age 79.8 (79.7–80) versus 74.7 (74.5–74.7) years; p < 0.001), than those in SR. In a multivariable analysis, AF was independently associated with mortality at all time points, in hospital (HR 1.15, 95% CI 1.09–1.21, p < 0.0001), 30 days (HR 1.13, 95% CI 1.08–1.19, p < 0.0001), and 1 year (HR 1.09, 95% CI 1.05–1.12, p < 0.0001). In subgroup analyses, AF was independently associated with worse 30-day outcome irrespective of sex, ventricular phenotype and in all age groups except in those aged between 55 and 74 years.

Conclusion

AF is independently associated with adverse prognosis in AHF during admission and up to 1 year post-discharge. As the clinical burden of concomitant AF and AHF increases, further refinement in the detection, treatment and prevention of AF-related complications may have a role in improving patient outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2014) Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004CrossRef McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2014) Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004CrossRef
2.
go back to reference Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1):11–21CrossRef Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364(1):11–21CrossRef
3.
go back to reference Gijsberts CM, Benson L, Dahlström U, Sim D, Yeo DPS, Ong HY et al (2016) Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure. Heart (British Cardiac Society) 102:1464–1471 Gijsberts CM, Benson L, Dahlström U, Sim D, Yeo DPS, Ong HY et al (2016) Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure. Heart (British Cardiac Society) 102:1464–1471
4.
go back to reference Emdin CA, Conrad N, Kiran A, Salimi-Khorshidi G, Woodward M, Anderson SG et al (2017) Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart 103(1):55–62CrossRef Emdin CA, Conrad N, Kiran A, Salimi-Khorshidi G, Woodward M, Anderson SG et al (2017) Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart 103(1):55–62CrossRef
5.
go back to reference Khan MA, Satchithananda DK, Mamas MA (2016) The importance of interactions between atrial fibrillation and heart failure. Clin Med (Lond, Engl) 16(3):272–276CrossRef Khan MA, Satchithananda DK, Mamas MA (2016) The importance of interactions between atrial fibrillation and heart failure. Clin Med (Lond, Engl) 16(3):272–276CrossRef
6.
go back to reference Mamas MA, Caldwell JC, Chacko S, Garratt CJ, Fath-Ordoubadi F, Neyses L (2009) A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Failure 11(7):676–683CrossRef Mamas MA, Caldwell JC, Chacko S, Garratt CJ, Fath-Ordoubadi F, Neyses L (2009) A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Failure 11(7):676–683CrossRef
7.
go back to reference Mountantonakis SE, Grau-Sepulveda MV, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC (2012) Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure. Circ Heart Fail 5(2):191–201CrossRef Mountantonakis SE, Grau-Sepulveda MV, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC (2012) Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure. Circ Heart Fail 5(2):191–201CrossRef
9.
go back to reference Llorens P, Javaloyes P, Martin-Sanchez FJ, Jacob J, Herrero-Puente P, Gil V et al (2018) Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure. Clin Res Cardiol 107(10):897–913CrossRef Llorens P, Javaloyes P, Martin-Sanchez FJ, Jacob J, Herrero-Puente P, Gil V et al (2018) Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure. Clin Res Cardiol 107(10):897–913CrossRef
10.
go back to reference Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM et al (2017) Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol 106(6):444–456CrossRef Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM et al (2017) Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol 106(6):444–456CrossRef
11.
go back to reference Rivero-Ayerza M, Scholte Op Reimer W, Lenzen M, Theuns DA, Jordaens L, Komajda M et al (2008) New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey. Eur Heart J 29(13):1618–1624CrossRef Rivero-Ayerza M, Scholte Op Reimer W, Lenzen M, Theuns DA, Jordaens L, Komajda M et al (2008) New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey. Eur Heart J 29(13):1618–1624CrossRef
12.
go back to reference Pedersen OD, Sondergaard P, Nielsen T, Nielsen SJ, Nielsen ES, Falstie-Jensen N et al (2006) Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur Heart J 27(23):2866–2870CrossRef Pedersen OD, Sondergaard P, Nielsen T, Nielsen SJ, Nielsen ES, Falstie-Jensen N et al (2006) Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur Heart J 27(23):2866–2870CrossRef
14.
go back to reference Miro O, Gil VI, Martin-Sanchez FJ, Jacob J, Herrero P, Alquezar A et al (2018) Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care. Clin Res Cardiol 107(8):698–710CrossRef Miro O, Gil VI, Martin-Sanchez FJ, Jacob J, Herrero P, Alquezar A et al (2018) Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care. Clin Res Cardiol 107(8):698–710CrossRef
15.
go back to reference Meyer S, Teerlink JR, Metra M, Ponikowski P, Cotter G, Davison BA et al (2017) Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study. Clin Res Cardiol 106(4):280–292CrossRef Meyer S, Teerlink JR, Metra M, Ponikowski P, Cotter G, Davison BA et al (2017) Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study. Clin Res Cardiol 106(4):280–292CrossRef
16.
go back to reference Cleland JG, McDonagh T, Rigby AS, Yassin A, Whittaker T, Dargie HJ (2011) The national heart failure audit for England and Wales 2008–2009. Heart 97(11):876–886CrossRef Cleland JG, McDonagh T, Rigby AS, Yassin A, Whittaker T, Dargie HJ (2011) The national heart failure audit for England and Wales 2008–2009. Heart 97(11):876–886CrossRef
18.
go back to reference Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28(25):3083–3107CrossRef Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28(25):3083–3107CrossRef
19.
go back to reference Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 18(6):805–835CrossRef Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 18(6):805–835CrossRef
20.
go back to reference Abualnaja S, Podder M, Hernandez AF, McMurray JJ, Starling RC, O’Connor CM et al (2015) Acute heart failure and atrial fibrillation: insights from the acute study of clinical effectiveness of nesiritide in decompensated heart failure (ASCEND-HF) trial. J Am Heart Assoc 4(8):e002092CrossRef Abualnaja S, Podder M, Hernandez AF, McMurray JJ, Starling RC, O’Connor CM et al (2015) Acute heart failure and atrial fibrillation: insights from the acute study of clinical effectiveness of nesiritide in decompensated heart failure (ASCEND-HF) trial. J Am Heart Assoc 4(8):e002092CrossRef
21.
go back to reference McDonagh T, Cleland J, Dargie HJ, Whittaker T, Standing M, Mitchell M et al (2012) National Heart Failure Audit April 2010–March 2011 McDonagh T, Cleland J, Dargie HJ, Whittaker T, Standing M, Mitchell M et al (2012) National Heart Failure Audit April 2010–March 2011
22.
go back to reference Anter E, Jessup M, Callans DJ (2009) Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 119(18):2516–2525CrossRef Anter E, Jessup M, Callans DJ (2009) Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 119(18):2516–2525CrossRef
23.
go back to reference Caldwell J, Mamas M, Garratt C, Neyses L (2008) How common is asymptomatic paroxysmal atrial fibrillation in chronic heart failure? Scand Cardiovasc J SCJ 42(6):366 (author reply 7) CrossRef Caldwell J, Mamas M, Garratt C, Neyses L (2008) How common is asymptomatic paroxysmal atrial fibrillation in chronic heart failure? Scand Cardiovasc J SCJ 42(6):366 (author reply 7) CrossRef
24.
go back to reference Kareti KR, Chiong JR, Hsu SS, Miller AB (2005) Congestive heart failure and atrial fibrillation: rhythm versus rate control. J Card Fail 11(3):164–172CrossRef Kareti KR, Chiong JR, Hsu SS, Miller AB (2005) Congestive heart failure and atrial fibrillation: rhythm versus rate control. J Card Fail 11(3):164–172CrossRef
25.
go back to reference Sramko M, Wichterle D, Melenovsky V, Franekova J, Clemens M, Fukunaga M et al (2019) Independent effect of atrial fibrillation on natriuretic peptide release. Clin Res Cardiol 108(2):142–149CrossRef Sramko M, Wichterle D, Melenovsky V, Franekova J, Clemens M, Fukunaga M et al (2019) Independent effect of atrial fibrillation on natriuretic peptide release. Clin Res Cardiol 108(2):142–149CrossRef
26.
go back to reference Llach A, Molina CE, Prat-Vidal C, Fernandes J, Casado V, Ciruela F et al (2011) Abnormal calcium handling in atrial fibrillation is linked to up-regulation of adenosine A2A receptors. Eur Heart J 32(6):721–729CrossRef Llach A, Molina CE, Prat-Vidal C, Fernandes J, Casado V, Ciruela F et al (2011) Abnormal calcium handling in atrial fibrillation is linked to up-regulation of adenosine A2A receptors. Eur Heart J 32(6):721–729CrossRef
27.
go back to reference Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs. Atrial Remodel Differ Sort 100(1):87–95 Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs. Atrial Remodel Differ Sort 100(1):87–95
28.
go back to reference Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. J Am Coll Cardiol 32(3):695–703CrossRef Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. J Am Coll Cardiol 32(3):695–703CrossRef
29.
go back to reference Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M et al (2005) Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 26(13):1303–1308CrossRef Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M et al (2005) Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 26(13):1303–1308CrossRef
30.
go back to reference Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84(1):40–48CrossRef Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84(1):40–48CrossRef
31.
go back to reference Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL et al (2011) Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 13(10):1111–1120CrossRef Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL et al (2011) Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 13(10):1111–1120CrossRef
32.
go back to reference Kotecha D, Chudasama R, Lane DA, Kirchhof P, Lip GY (2016) Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol 203:660–666CrossRef Kotecha D, Chudasama R, Lane DA, Kirchhof P, Lip GY (2016) Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol 203:660–666CrossRef
33.
go back to reference Kober L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R et al (2006) Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 8(6):591–598CrossRef Kober L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R et al (2006) Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 8(6):591–598CrossRef
34.
go back to reference Schneider MP, Hua TA, Böhm M, Wachtell K, Kjeldsen SE, Schmieder RE (2010) Prevention of atrial fibrillation by renin–angiotensin system inhibition. A meta-analysis. J Am Coll Cardiol 55(21):2299–2307CrossRef Schneider MP, Hua TA, Böhm M, Wachtell K, Kjeldsen SE, Schmieder RE (2010) Prevention of atrial fibrillation by renin–angiotensin system inhibition. A meta-analysis. J Am Coll Cardiol 55(21):2299–2307CrossRef
35.
go back to reference Jibrini MB, Molnar J, Arora RR (2008) Prevention of atrial fibrillation by way of abrogation of the renin–angiotensin system: a systematic review and meta-analysis. Am J Ther 15(1):36–43CrossRef Jibrini MB, Molnar J, Arora RR (2008) Prevention of atrial fibrillation by way of abrogation of the renin–angiotensin system: a systematic review and meta-analysis. Am J Ther 15(1):36–43CrossRef
36.
go back to reference Goette A, Schon N, Kirchhof P, Breithardt G, Fetsch T, Hausler KG et al (2012) Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Circ Arrhythm Electrophysio 5(1):43–51CrossRef Goette A, Schon N, Kirchhof P, Breithardt G, Fetsch T, Hausler KG et al (2012) Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Circ Arrhythm Electrophysio 5(1):43–51CrossRef
37.
go back to reference Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG et al (2011) Irbesartan in patients with atrial fibrillation. N Engl J Med 364(10):928–938CrossRef Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG et al (2011) Irbesartan in patients with atrial fibrillation. N Engl J Med 364(10):928–938CrossRef
40.
go back to reference Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H et al (2012) Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J Am Coll Cardiol 59(18):1598–1603CrossRef Swedberg K, Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Shi H et al (2012) Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J Am Coll Cardiol 59(18):1598–1603CrossRef
41.
go back to reference Farmakis D, Simitsis P, Bistola V, Triposkiadis F, Ikonomidis I, Katsanos S et al (2017) Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome. Clin Res Cardiol 106(5):359–368CrossRef Farmakis D, Simitsis P, Bistola V, Triposkiadis F, Ikonomidis I, Katsanos S et al (2017) Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome. Clin Res Cardiol 106(5):359–368CrossRef
42.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Revista espanola de cardiologia (Engl ed) 69(12):1167 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Revista espanola de cardiologia (Engl ed) 69(12):1167
Metadata
Title
Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit
Authors
Simon G. Anderson
Ahmad Shoaib
Phyo Kyaw Myint
John G. Cleland
Suzanna M. Hardman
Theresa A. McDonagh
Henry Dargie
Bernard Keavney
Clifford J. Garratt
Mamas A. Mamas
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 11/2019
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-019-01463-5

Other articles of this Issue 11/2019

Clinical Research in Cardiology 11/2019 Go to the issue